Sulfamerazine EP Standard from Canada
Sulfamerazine, a short-acting sulfonamide antibiotic explicitly listed in HTS 2935.90.4200, meets European Pharmacopoeia standards for purity. Used in combination therapies for urinary tract infections, this bulk API represents a classic Chapter 29 sulfonamide classification. The product qualifies due to its specific chemical definition and anti-infective drug application.
Duty Rate — Canada → United States
110%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide EP certificate of analysis and demonstrate US pharmacopeial equivalence for faster FDA clearance
• Declare exact isomeric purity as mixtures of isomers follow specific Chapter 29 note 2(b) classification rules
• Avoid misclassification by specifying human pharmaceutical use vs research chemical applications